In addition to APOE, other risk variants in genes for late-onset AD, including ADAM10, ADAMTS1, MAPT, GRN, ARSA, and CSF1R, are involved in APP and tau metabolism [7]. The gene discussed is MAPT; the disease is Alzheimer disease.